Residency · Residency · Ophthalmology

Primary Open-Angle Glaucoma: Diagnosis and Staging

Definition

Primary open-angle glaucoma (POAG) is a chronic, progressive optic neuropathy characterized by specific patterns of optic nerve head damage and corresponding visual field loss. By definition, the anterior chamber angle appears open and normal on gonioscopy. A critical conceptual point is that intraocular pressure, while the most important modifiable risk factor, is not part of the definition of glaucoma -- the disease is defined by the optic neuropathy itself. POAG is the most common form of glaucoma worldwide.

Epidemiology

POAG affects 1 to 3% of the population over age 40, with prevalence increasing substantially with advancing age. It is the leading cause of irreversible blindness worldwide. Populations of African descent have a three- to four-fold higher prevalence, with earlier onset and a more aggressive disease course. The major risk factors include older age, elevated IOP, family history of glaucoma, African or Hispanic ancestry, thin central corneal thickness, myopia, disc hemorrhages, and low ocular perfusion pressure.

Pathophysiology

The pathogenesis of POAG is multifactorial and cannot be reduced to elevated IOP alone. The fundamental pathology is the progressive loss of retinal ganglion cells (RGCs) and their axons at the optic nerve head. Three principal theories explain how this damage occurs. The mechanical theory proposes that elevated IOP compresses and deforms the lamina cribrosa, physically damaging RGC axons as they pass through the laminar pores. The vascular theory implicates reduced blood flow to the optic nerve head, whether through vasospasm, low perfusion pressure, or nocturnal systemic hypotension. The biomechanical theory focuses on the inherent susceptibility of the lamina cribrosa, which varies with its connective tissue composition and capacity for remodeling under stress.

In most cases, trabecular meshwork dysfunction leads to decreased outflow facility and elevated IOP, which drives the damage. However, normal-tension glaucoma (NTG) -- in which IOP is consistently at or below 21 mmHg -- demonstrates that vascular and biomechanical factors can cause glaucomatous optic neuropathy even at statistically normal pressures. NTG is associated with migraine, Raynaud phenomenon, sleep apnea, and nocturnal systemic hypotension, conditions that suggest vascular dysregulation plays a prominent role.

Risk Factor Assessment

Ocular Hypertension Treatment Study (OHTS)

The OHTS was a landmark trial that defined the risk factors for conversion from ocular hypertension (elevated IOP without optic nerve damage) to POAG. The identified risk factors include higher baseline IOP, thinner CCT (below 555 micrometers), larger vertical cup-to-disc ratio, older age, and higher pattern standard deviation on visual field testing. The five-year conversion rate was approximately 10% in untreated patients compared with 5% in treated patients, representing a 50% risk reduction with treatment. The OHTS risk calculator, derived from these data, is used clinically to guide treatment decisions in patients with ocular hypertension.

Key Landmark Trials

Several landmark trials form the evidence base for glaucoma management. The OHTS demonstrated that treating ocular hypertension reduces conversion to glaucoma by 50%. The Early Manifest Glaucoma Trial (EMGT) found that each 1 mmHg reduction in IOP reduced the risk of progression by approximately 10%, and overall treatment reduced progression by 50%. The Advanced Glaucoma Intervention Study (AGIS) showed that eyes maintaining IOP consistently below 18 mmHg had minimal visual field progression. The Collaborative Normal Tension Glaucoma Study (CNTGS) demonstrated that a 30% IOP reduction slowed progression even in eyes with normal-tension glaucoma, confirming that IOP lowering benefits these patients. The UK Glaucoma Treatment Study (UKGTS) showed that latanoprost preserved visual fields compared with placebo in newly diagnosed POAG, providing the first placebo-controlled evidence for a single medication.

Clinical Examination

Optic Nerve Head Assessment

Careful optic nerve head evaluation is the cornerstone of glaucoma diagnosis. The cup-to-disc ratio (C/D) is assessed, with progressive enlargement -- particularly in the vertical dimension -- being the hallmark of glaucomatous damage. Neuroretinal rim thinning follows a predictable pattern: in healthy eyes, the rim is thickest inferiorly, then superiorly, then nasally, and thinnest temporally -- the ISNT rule. Loss of this normal pattern suggests glaucomatous damage, with the inferior and superior poles being the most vulnerable.

Disc hemorrhages, also called Drance hemorrhages, are flame-shaped hemorrhages at the disc margin that represent one of the strongest predictors of glaucoma progression. They are transient, lasting only weeks, and are frequently missed if the examiner does not look carefully at every visit. Notching refers to focal thinning of the neuroretinal rim, often seen inferiorly or superiorly. The bayonetting sign describes sharp angulation of blood vessels at the disc margin caused by loss of underlying rim tissue. As the cup enlarges, blood vessels shift nasally -- another sign of progressive cupping. Peripapillary atrophy, specifically the beta-zone (characterized by loss of RPE and photoreceptors adjacent to the disc), is associated with glaucoma progression. The laminar dot sign refers to exposed lamina cribrosa pores visible in the base of the cup, indicating significant tissue loss.

Asymmetry

A cup-to-disc ratio asymmetry greater than 0.2 between the two eyes is suspicious for glaucoma. However, disc size must be considered when interpreting this finding, because larger discs normally have larger cups as a physiologic variant.

Structural Assessment (OCT)

Retinal Nerve Fiber Layer (RNFL)

OCT measures peripapillary RNFL thickness around a 3.4 mm diameter circle centered on the optic disc, comparing values to an age-matched normative database. Results are color-coded: green for normal, yellow for borderline or suspect, and red for outside normal limits. The inferior and superior RNFL sectors are the first to be affected in glaucoma, corresponding to the vulnerability of the superior and inferior nerve fiber bundles. Importantly, RNFL loss often precedes detectable visual field loss, a stage known as pre-perimetric glaucoma, making OCT valuable for early detection. Limitations include measurement artifacts from high myopia, peripapillary atrophy, and tilted discs.

Ganglion Cell Complex (GCC) / Ganglion Cell-Inner Plexiform Layer (GCIPL)

Macular analysis of ganglion cell layer thickness provides a useful complement to RNFL assessment. Because the macula contains the highest density of ganglion cells, macular scanning can detect early glaucomatous damage, sometimes before RNFL changes are apparent. Macular measurements are also less affected by the disc anatomy artifacts that can confound RNFL analysis.

Optic Nerve Head (ONH) Parameters

OCT-derived ONH parameters include rim area, disc area, cup volume, and C/D ratio. A newer and potentially more accurate measurement is the Bruch membrane opening-based minimum rim width (BMO-MRW), which measures the minimum distance from the edge of Bruch membrane opening to the internal limiting membrane. BMO-MRW may be more anatomically precise than traditional C/D ratio assessment because it uses a consistent anatomical reference point.

Functional Assessment (Visual Fields)

Standard Automated Perimetry (SAP)

The Humphrey Visual Field (HVF) analyzer is the most widely used perimetric instrument for glaucoma. Testing strategies include SITA-Standard, SITA-Fast, and the newer SITA-Faster, which reduce test time while maintaining accuracy. The 24-2 test pattern is the standard for glaucoma assessment, while the 10-2 pattern tests the central field and is used for advanced glaucoma and when macular involvement is suspected. The standard stimulus size is Goldmann III.

Reliability Indices

Every visual field must be assessed for reliability before interpretation. Fixation losses should be below 20%, monitored by blind spot checks or gaze tracking. False positives should be below 15% -- a high rate indicates a "trigger-happy" patient whose responses may inflate sensitivity values. False negatives should be below 33% -- a high rate suggests an inattentive patient whose field may appear worse than reality. A high false-positive rate is particularly problematic because it invalidates the field, and testing should be repeated.

Visual Field Patterns in Glaucoma

Glaucomatous visual field defects follow characteristic patterns that reflect the anatomy of the retinal nerve fiber layer. A paracentral scotoma involves loss near fixation (within 10 degrees) and is particularly important because of its functional impact on reading and central vision. An arcuate or Bjerrum scotoma is an arching defect that follows the RNFL distribution from the blind spot. A nasal step (Roenne nasal step) is asymmetric sensitivity loss across the horizontal meridian in the nasal field, reflecting the fact that the superior and inferior arcuate nerve fiber bundles do not overlap at the horizontal raphe. An altitudinal defect involves loss above or below the horizontal meridian. Generalized depression represents diffuse reduction in sensitivity across the field, which may reflect cataract, small pupil, or advanced glaucoma. A temporal wedge corresponds to loss of the nasal papillomacular RNFL bundle. In end-stage glaucoma, the central and temporal islands of vision are the last to be preserved.

Global Indices

The mean deviation (MD) represents the average deviation from age-corrected normal sensitivity values; more negative values indicate worse fields. MD is used to stage severity: mild is better than -6 dB, moderate is -6 to -12 dB, and severe is worse than -12 dB. The pattern standard deviation (PSD) measures localized or focal loss -- it is elevated when focal defects are present and remains low with purely diffuse loss. The Visual Field Index (VFI) expresses the percentage of remaining visual field function on a scale from 100% (normal) to 0% (blind) and is particularly useful for trend-based rate of progression analysis. The Glaucoma Hemifield Test (GHT) compares corresponding zones between the superior and inferior hemifields, reporting results as within normal limits, borderline, or outside normal limits.

Staging of Glaucoma Severity

Hodapp-Parrish-Anderson (HPA) Classification

The HPA classification stages glaucoma severity based on visual field MD and the pattern of visual field loss. Mild glaucoma is defined by MD better than -6 dB, no point within 5 degrees of fixation below 15 dB, fewer than 25% of points depressed below the 5% probability level, and fewer than 10 points below the 1% probability level. Moderate glaucoma has MD between -6 and -12 dB, no point within 5 degrees of fixation at 0 dB, fewer than 50% of points below 5% probability, and one hemifield with sensitivity below 15 dB within 5 degrees of fixation. Severe glaucoma has MD worse than -12 dB, at least 50% of points below 5% probability, and points within 5 degrees of fixation at 0 dB.

ICD-Based Staging

The ICD classification categorizes glaucoma as mild, moderate, severe, or indeterminate based on a combination of visual field and structural findings.

Monitoring for Progression

Structure-Function Correlation

The relationship between structural and functional damage changes with disease severity. In early disease, structural assessment with OCT (RNFL and GCC) often detects damage before functional loss is measurable on visual fields, making OCT the more sensitive tool for early detection and progression monitoring. In moderate to severe disease, however, RNFL thickness reaches a measurement floor -- plateauing at approximately 40 to 50 micrometers regardless of further ganglion cell loss -- and visual field testing becomes more informative for tracking progression. The best approach is to use both modalities together throughout the course of the disease.

Rate of Progression

Progression can be assessed by several methods. Guided Progression Analysis (GPA) is an event-based approach that compares individual fields to a baseline to detect significant change. VFI trend analysis calculates the rate of change in VFI over time as the slope of a regression line, providing a quantitative measure of how fast the field is deteriorating. OCT progression analysis uses trend-based tracking of RNFL or GCC thickness change over serial measurements. The rate of progression is clinically critical because faster progression demands more aggressive treatment and a lower target IOP.

Target IOP

No single target IOP is appropriate for all patients. The target is individualized based on the severity of existing damage, the rate of progression, the baseline IOP, life expectancy, and the constellation of risk factors present. General guidelines suggest a 20 to 25% reduction from baseline (or a target below 18 mmHg) for mild glaucoma, a 25 to 30% reduction (or a target below 15 mmHg) for moderate disease, and a 30 to 50% reduction (or a target below 12 mmHg) for severe or rapidly progressing cases. For normal-tension glaucoma, a 30% reduction from baseline is the standard target derived from the CNTGS.

<image>Optic nerve head comparison montage. Left: Normal optic nerve with healthy neuroretinal rim following the ISNT rule (thickest inferiorly, thinnest temporally), small cup, and no peripapillary changes. Right: Glaucomatous optic nerve showing enlarged vertical cup-to-disc ratio, inferior notching of the neuroretinal rim, loss of the ISNT pattern, disc hemorrhage at the 7 o'clock position (Drance hemorrhage with arrow), bayonetting of vessels at the rim margin, nasal shift of blood vessels, and beta-zone peripapillary atrophy. Both nerves shown with surrounding RNFL in red-free photography with visible RNFL defect in the glaucomatous eye.</image>

<image>Humphrey Visual Field printout with labeled components for a moderate glaucoma patient. The printout shows: (1) Gray scale showing a superior arcuate scotoma; (2) Total deviation probability plot with cluster of depressed points in the superior arcuate pattern; (3) Pattern deviation plot highlighting the focal loss after removing any generalized depression; (4) Global indices box showing MD of -8.5 dB, PSD of 6.2 dB, and GHT "outside normal limits"; (5) Reliability indices showing fixation losses <20%, false positives <15%, and false negatives <33%. Annotate the arcuate defect, nasal step, and the significance of each global index.</image>

<image>OCT analysis of glaucoma showing structural damage. Four panels: (1) RNFL thickness map — peripapillary circle showing thinning inferiorly and superiorly with the RNFL plotted on a TSNIT graph with values falling into the red zone inferiorly; (2) RNFL deviation map showing areas of abnormal thinning highlighted in red/yellow; (3) Ganglion cell-inner plexiform layer (GCIPL) macular thickness map showing thinning in the inferior hemifield (corresponding to a superior visual field defect); (4) Optic nerve head analysis showing BMO-MRW measurements with inferior and superior thinning. Include the normative database color coding (green/yellow/red) and numerical values.</image>

Key Clinical Pearls

Glaucoma is defined by optic neuropathy, not by a specific IOP level -- normal-tension glaucoma occurs at statistically normal pressures, and conversely, many patients with elevated IOP never develop glaucoma. Disc hemorrhages are one of the strongest predictors of progression, but because they are transient (lasting only weeks) they are easily missed and must be actively sought at every visit. The standard 24-2 visual field may miss paracentral damage near fixation; if macular GCC or GCIPL analysis shows thinning with a normal-appearing 24-2 field, a 10-2 test should be obtained. OCT detects glaucomatous structural damage before visual field loss in early disease, making RNFL and GCC analysis essential for early detection. In advanced glaucoma, OCT has a floor effect -- RNFL thickness plateaus at approximately 40 to 50 micrometers regardless of further damage -- so visual fields become the more important tool for monitoring progression. The rate of progression is as important as whether progression has occurred: a patient losing 2 dB per year requires far more aggressive treatment than one losing 0.3 dB per year. Central corneal thickness is an independent risk factor that operates through two mechanisms: thin corneas cause IOP to be underestimated by Goldmann tonometry, and thin CCT may also reflect the biomechanical properties of the lamina cribrosa, independently increasing susceptibility to glaucomatous damage. A family history of glaucoma increases risk four- to nine-fold, and first-degree relatives should be screened.

References

• Kass MA, et al. The Ocular Hypertension Treatment Study (OHTS). Arch Ophthalmol. 2002;120(6):701-713.
• Heijl A, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120(10):1268-1279.
• Garway-Heath DF, et al. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet. 2015;385(9975):1295-1304.
• Weinreb RN, et al. Primary open-angle glaucoma. Nat Rev Dis Primers. 2016;2:16067.
• AAO BCSC Section 10: Glaucoma. 2023-2024.

Read this lecture as Markdown